CP 060;4-Thiazolidinone, 3-[3-[[2-(1,3-benzodioxol-5-yloxy)ethyl]methylamino]propyl]-2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-;CP060,CP 060;CP-060, 10 mM in DMSO
CP-060 is a Ca²⁺ antagonist that inhibits calcium overload, exhibits antioxidant activity, and provides cardioprotective effects; it inhibits soybean lipoxygenase-induced rabbit LDL oxidation in vitro (by 12.9% and 3.0% at 0.5 and 5 μM, respectively); and increases coronary blood flow by 96% in anesthetized dogs when administered intravenously at 100 mg/kg.